 |
| |
| |
| |
| |
| |
| |
|
| TissGeneSummary for TTC30A |
 Gene summary |
| Basic gene information | Gene symbol | TTC30A |
| Gene name | tetratricopeptide repeat domain 30A | |
| Synonyms | - | |
| Cytomap | UCSC genome browser: 2q31.2 | |
| Type of gene | protein-coding | |
| RefGenes | NM_152275.3, | |
| Description | TPR repeat protein 30Atetratricopeptide repeat protein 30A | |
| Modification date | 20141207 | |
| dbXrefs | HGNC : HGNC | |
| HPRD : 08590 | ||
| Protein | UniProt: go to UniProt's Cross Reference DB Table | |
| Expression | CleanEX: HS_TTC30A | |
| BioGPS: 92104 | ||
| Pathway | NCI Pathway Interaction Database: TTC30A | |
| KEGG: TTC30A | ||
| REACTOME: TTC30A | ||
| Pathway Commons: TTC30A | ||
| Context | iHOP: TTC30A | |
| ligand binding site mutation search in PubMed: TTC30A | ||
| UCL Cancer Institute: TTC30A | ||
| Assigned class in TissGDB* | C | |
| Included tissue-specific gene expression resources | ||
| Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | Bone marrowTestis | |
| Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | LAMLTGCT | |
| Reference showing the relevant tissue of TTC30A | ||
| Description by TissGene annotations | TissgsLTS | |
| * Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
| Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
| GO ID | GO term | PubMed ID |
| Top |
| TissGeneExp for TTC30A |
| Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
 |
| Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
 |
| Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
 |
| Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
 |
| - Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
| Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
| THCA | -0.602772769 | 0.854456045 | -1.457228814 | 3.60E-24 | 4.19E-22 |
| KICH | -0.910823752 | 0.870044248 | -1.780868 | 7.21E-14 | 1.09E-12 |
| Top |
| TissGene-miRNA for TTC30A |
| Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
| Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
| Top |
| TissGeneMut for TTC30A |
| TissGeneSNV for TTC30A |
| nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
 |
| Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
 |
| - nsSNVs sorted by frequency. |
| AAchange | Cancer type | # samples |
| p.E421D | UCEC | 1 |
| p.G662V | CESC | 1 |
| p.A412T | UCEC | 1 |
| p.A110V | PAAD | 1 |
| p.R220C | SKCM | 1 |
| p.E388Q | BLCA | 1 |
| p.A102T | CESC | 1 |
| p.R220H | DLBC | 1 |
| p.G662X | COAD | 1 |
| p.R117H | UCEC | 1 |
| p.Q610K | LUSC | 1 |
| p.K445N | BLCA | 1 |
| p.G228D | GBM | 1 |
| p.E611Q | BLCA | 1 |
| p.E415K | ESCA | 1 |
| p.R237C | COAD | 1 |
| p.P319S | SKCM | 1 |
| p.H542Y | SKCM | 1 |
| p.D24Y | BLCA | 1 |
| p.E444K | SKCM | 1 |
| p.R301M | UCEC | 1 |
| p.E477* | UCEC | 1 |
| p.S497T | UCEC | 1 |
| p.G623V | OV | 1 |
| p.E399K | BLCA | 1 |
| p.A294T | UCEC | 1 |
| p.A7V | STAD | 1 |
| p.E153Q | CESC | 1 |
| p.E611X | COAD | 1 |
| p.L208V | LIHC | 1 |
| p.Q293K | THYM | 1 |
| p.D24H | LIHC | 1 |
| p.G156C | STAD | 1 |
| p.W663C | STAD | 1 |
| p.A88V | UCEC | 1 |
| p.N266I | HNSC | 1 |
| p.R114W | PRAD | 1 |
| p.K411N | PAAD | 1 |
| p.K395T | DLBC | 1 |
| p.E388Q | HNSC | 1 |
| p.R237S | ESCA | 1 |
| p.A173V | UCEC | 1 |
| p.E37Q | LUAD | 1 |
| p.I630V | STAD | 1 |
| p.A364T | KIRC | 1 |
| p.S184L | BLCA | 1 |
| p.R404T | BLCA | 1 |
| p.A347V | PRAD | 1 |
| p.E29K | LUAD | 1 |
| p.R133K | STAD | 1 |
| p.D363H | BLCA | 1 |
| p.D11N | STAD | 1 |
| p.A498T | UCEC | 1 |
| p.N152K | HNSC | 1 |
| p.E224Q | HNSC | 1 |
| p.S178C | CESC | 1 |
| p.N439K | UCEC | 1 |
| p.M296I | UCEC | 1 |
| p.K557R | HNSC | 1 |
| p.R638I | UCEC | 1 |
| p.D11N | BLCA | 1 |
| Top |
| TissGeneCNV for TTC30A |
| Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
 |
| Top |
| TissGeneFusions for TTC30A |
| Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
| Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
| Top |
| TissGeneNet for TTC30A |
| Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
| BRCA (tumor) | BRCA (normal) |
| TTC30A, EEF1D (tumor) | TTC30A, EEF1D (normal) |
 |  |
| COAD (tumor) | COAD (normal) |
| TTC30A, EEF1D (tumor) | TTC30A, EEF1D (normal) |
 |  |
| HNSC (tumor) | HNSC (normal) |
| TTC30A, EEF1D (tumor) | TTC30A, EEF1D (normal) |
 |  |
| KICH (tumor) | KICH (normal) |
| TTC30A, EEF1D (tumor) | TTC30A, EEF1D (normal) |
 |  |
| KIRC (tumor) | KIRC (normal) |
| TTC30A, EEF1D (tumor) | TTC30A, EEF1D (normal) |
 |  |
| KIRP (tumor) | KIRP (normal) |
| TTC30A, EEF1D (tumor) | TTC30A, EEF1D (normal) |
 |  |
| LIHC (tumor) | LIHC (normal) |
| TTC30A, EEF1D (tumor) | TTC30A, EEF1D (normal) |
 |  |
| LUAD (tumor) | LUAD (normal) |
| TTC30A, EEF1D (tumor) | TTC30A, EEF1D (normal) |
 |  |
| LUSC (tumor) | LUSC (normal) |
| TTC30A, EEF1D (tumor) | TTC30A, EEF1D (normal) |
 |  |
| PRAD (tumor) | PRAD (normal) |
| TTC30A, EEF1D (tumor) | TTC30A, EEF1D (normal) |
 |  |
| STAD (tumor) | STAD (normal) |
| TTC30A, EEF1D (tumor) | TTC30A, EEF1D (normal) |
 |  |
| THCA (tumor) | THCA (normal) |
| TTC30A, EEF1D (tumor) | TTC30A, EEF1D (normal) |
 |  |
| Top |
| TissGeneProg for TTC30A |
| Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
 |
| Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
 |
| Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
 |
| Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
 |
| Top |
| TissGeneClin for TTC30A |
| TissGeneDrug for TTC30A |
| Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
| DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Top |
| TissGeneDisease for TTC30A |
| Disease information associated with TissGene (DisGeNet, 2016-06-01) |
| Disease ID | Disease name | # pubmeds | Source |
| umls:C1561955 | Fibrinogen Adverse Event | 1 | GAD |
Copyright 2016-Present - The University of Texas Health Science Center at Houston (UTHealth) Web File Viewing | How to Report, Fraud, Waste and Abuse | State of Texas | Statewide Search | Texas Homeland Security | Site Policies |